Global Anti-TIGIT Antibody Market Research Report 2024(Status and Outlook)
![](/report_cover/11711/global-anti-tigit-antibody-market-research-report-2024status-n-outlook_en.gif)
Report Overview:
A human monoclonal antibody targeting the co-inhibitory molecule and immune checkpoint inhibitor T-cell immunoreceptor with immunoglobulin (Ig) and immunoreceptor tyrosine-based inhibitory motif (ITIM) domains (TIGIT), with potential immune checkpoint inhibitory activity.
The Global Anti-TIGIT Antibody Market Size was estimated at USD 368.95 million in 2023 and is projected to reach USD 788.75 million by 2029, exhibiting a CAGR of 13.50% during the forecast period.
This report provides a deep insight into the global Anti-TIGIT Antibody market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-TIGIT Antibody Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-TIGIT Antibody market in any manner.
Global Anti-TIGIT Antibody Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Merck
AstraZeneca
Arcus
Astellas
BeiGene
BMS
Junshi Biosciences
Innovent Biologics
Mereo BioPharma
Seattle Genetics
Hengrui Medicine
Compugen
Gilead Sciences
Market Segmentation (by Type)
Monotherapy
Combination Therapy
Market Segmentation (by Application)
Cell Carcinoma
Solid Tumor
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-TIGIT Antibody Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
A human monoclonal antibody targeting the co-inhibitory molecule and immune checkpoint inhibitor T-cell immunoreceptor with immunoglobulin (Ig) and immunoreceptor tyrosine-based inhibitory motif (ITIM) domains (TIGIT), with potential immune checkpoint inhibitory activity.
The Global Anti-TIGIT Antibody Market Size was estimated at USD 368.95 million in 2023 and is projected to reach USD 788.75 million by 2029, exhibiting a CAGR of 13.50% during the forecast period.
This report provides a deep insight into the global Anti-TIGIT Antibody market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-TIGIT Antibody Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-TIGIT Antibody market in any manner.
Global Anti-TIGIT Antibody Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Merck
AstraZeneca
Arcus
Astellas
BeiGene
BMS
Junshi Biosciences
Innovent Biologics
Mereo BioPharma
Seattle Genetics
Hengrui Medicine
Compugen
Gilead Sciences
Market Segmentation (by Type)
Monotherapy
Combination Therapy
Market Segmentation (by Application)
Cell Carcinoma
Solid Tumor
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Anti-TIGIT Antibody Market
- Overview of the regional outlook of the Anti-TIGIT Antibody Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-TIGIT Antibody Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Anti-TIGIT Antibody
1.2 Key Market Segments
1.2.1 Anti-TIGIT Antibody Segment by Type
1.2.2 Anti-TIGIT Antibody Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTI-TIGIT ANTIBODY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Anti-TIGIT Antibody Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Anti-TIGIT Antibody Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTI-TIGIT ANTIBODY MARKET COMPETITIVE LANDSCAPE
3.1 Global Anti-TIGIT Antibody Sales by Manufacturers (2019-2024)
3.2 Global Anti-TIGIT Antibody Revenue Market Share by Manufacturers (2019-2024)
3.3 Anti-TIGIT Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti-TIGIT Antibody Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anti-TIGIT Antibody Sales Sites, Area Served, Product Type
3.6 Anti-TIGIT Antibody Market Competitive Situation and Trends
3.6.1 Anti-TIGIT Antibody Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-TIGIT Antibody Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTI-TIGIT ANTIBODY INDUSTRY CHAIN ANALYSIS
4.1 Anti-TIGIT Antibody Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTI-TIGIT ANTIBODY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTI-TIGIT ANTIBODY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-TIGIT Antibody Sales Market Share by Type (2019-2024)
6.3 Global Anti-TIGIT Antibody Market Size Market Share by Type (2019-2024)
6.4 Global Anti-TIGIT Antibody Price by Type (2019-2024)
7 ANTI-TIGIT ANTIBODY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-TIGIT Antibody Market Sales by Application (2019-2024)
7.3 Global Anti-TIGIT Antibody Market Size (M USD) by Application (2019-2024)
7.4 Global Anti-TIGIT Antibody Sales Growth Rate by Application (2019-2024)
8 ANTI-TIGIT ANTIBODY MARKET SEGMENTATION BY REGION
8.1 Global Anti-TIGIT Antibody Sales by Region
8.1.1 Global Anti-TIGIT Antibody Sales by Region
8.1.2 Global Anti-TIGIT Antibody Sales Market Share by Region
8.2 North America
8.2.1 North America Anti-TIGIT Antibody Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-TIGIT Antibody Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-TIGIT Antibody Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-TIGIT Antibody Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-TIGIT Antibody Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Roche
9.1.1 Roche Anti-TIGIT Antibody Basic Information
9.1.2 Roche Anti-TIGIT Antibody Product Overview
9.1.3 Roche Anti-TIGIT Antibody Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Anti-TIGIT Antibody SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Merck
9.2.1 Merck Anti-TIGIT Antibody Basic Information
9.2.2 Merck Anti-TIGIT Antibody Product Overview
9.2.3 Merck Anti-TIGIT Antibody Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Anti-TIGIT Antibody SWOT Analysis
9.2.6 Merck Recent Developments
9.3 AstraZeneca
9.3.1 AstraZeneca Anti-TIGIT Antibody Basic Information
9.3.2 AstraZeneca Anti-TIGIT Antibody Product Overview
9.3.3 AstraZeneca Anti-TIGIT Antibody Product Market Performance
9.3.4 AstraZeneca Anti-TIGIT Antibody SWOT Analysis
9.3.5 AstraZeneca Business Overview
9.3.6 AstraZeneca Recent Developments
9.4 Arcus
9.4.1 Arcus Anti-TIGIT Antibody Basic Information
9.4.2 Arcus Anti-TIGIT Antibody Product Overview
9.4.3 Arcus Anti-TIGIT Antibody Product Market Performance
9.4.4 Arcus Business Overview
9.4.5 Arcus Recent Developments
9.5 Astellas
9.5.1 Astellas Anti-TIGIT Antibody Basic Information
9.5.2 Astellas Anti-TIGIT Antibody Product Overview
9.5.3 Astellas Anti-TIGIT Antibody Product Market Performance
9.5.4 Astellas Business Overview
9.5.5 Astellas Recent Developments
9.6 BeiGene
9.6.1 BeiGene Anti-TIGIT Antibody Basic Information
9.6.2 BeiGene Anti-TIGIT Antibody Product Overview
9.6.3 BeiGene Anti-TIGIT Antibody Product Market Performance
9.6.4 BeiGene Business Overview
9.6.5 BeiGene Recent Developments
9.7 BMS
9.7.1 BMS Anti-TIGIT Antibody Basic Information
9.7.2 BMS Anti-TIGIT Antibody Product Overview
9.7.3 BMS Anti-TIGIT Antibody Product Market Performance
9.7.4 BMS Business Overview
9.7.5 BMS Recent Developments
9.8 Junshi Biosciences
9.8.1 Junshi Biosciences Anti-TIGIT Antibody Basic Information
9.8.2 Junshi Biosciences Anti-TIGIT Antibody Product Overview
9.8.3 Junshi Biosciences Anti-TIGIT Antibody Product Market Performance
9.8.4 Junshi Biosciences Business Overview
9.8.5 Junshi Biosciences Recent Developments
9.9 Innovent Biologics
9.9.1 Innovent Biologics Anti-TIGIT Antibody Basic Information
9.9.2 Innovent Biologics Anti-TIGIT Antibody Product Overview
9.9.3 Innovent Biologics Anti-TIGIT Antibody Product Market Performance
9.9.4 Innovent Biologics Business Overview
9.9.5 Innovent Biologics Recent Developments
9.10 Mereo BioPharma
9.10.1 Mereo BioPharma Anti-TIGIT Antibody Basic Information
9.10.2 Mereo BioPharma Anti-TIGIT Antibody Product Overview
9.10.3 Mereo BioPharma Anti-TIGIT Antibody Product Market Performance
9.10.4 Mereo BioPharma Business Overview
9.10.5 Mereo BioPharma Recent Developments
9.11 Seattle Genetics
9.11.1 Seattle Genetics Anti-TIGIT Antibody Basic Information
9.11.2 Seattle Genetics Anti-TIGIT Antibody Product Overview
9.11.3 Seattle Genetics Anti-TIGIT Antibody Product Market Performance
9.11.4 Seattle Genetics Business Overview
9.11.5 Seattle Genetics Recent Developments
9.12 Hengrui Medicine
9.12.1 Hengrui Medicine Anti-TIGIT Antibody Basic Information
9.12.2 Hengrui Medicine Anti-TIGIT Antibody Product Overview
9.12.3 Hengrui Medicine Anti-TIGIT Antibody Product Market Performance
9.12.4 Hengrui Medicine Business Overview
9.12.5 Hengrui Medicine Recent Developments
9.13 Compugen
9.13.1 Compugen Anti-TIGIT Antibody Basic Information
9.13.2 Compugen Anti-TIGIT Antibody Product Overview
9.13.3 Compugen Anti-TIGIT Antibody Product Market Performance
9.13.4 Compugen Business Overview
9.13.5 Compugen Recent Developments
9.14 Gilead Sciences
9.14.1 Gilead Sciences Anti-TIGIT Antibody Basic Information
9.14.2 Gilead Sciences Anti-TIGIT Antibody Product Overview
9.14.3 Gilead Sciences Anti-TIGIT Antibody Product Market Performance
9.14.4 Gilead Sciences Business Overview
9.14.5 Gilead Sciences Recent Developments
10 ANTI-TIGIT ANTIBODY MARKET FORECAST BY REGION
10.1 Global Anti-TIGIT Antibody Market Size Forecast
10.2 Global Anti-TIGIT Antibody Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anti-TIGIT Antibody Market Size Forecast by Country
10.2.3 Asia Pacific Anti-TIGIT Antibody Market Size Forecast by Region
10.2.4 South America Anti-TIGIT Antibody Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Anti-TIGIT Antibody by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Anti-TIGIT Antibody Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Anti-TIGIT Antibody by Type (2025-2030)
11.1.2 Global Anti-TIGIT Antibody Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Anti-TIGIT Antibody by Type (2025-2030)
11.2 Global Anti-TIGIT Antibody Market Forecast by Application (2025-2030)
11.2.1 Global Anti-TIGIT Antibody Sales (Kilotons) Forecast by Application
11.2.2 Global Anti-TIGIT Antibody Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Anti-TIGIT Antibody
1.2 Key Market Segments
1.2.1 Anti-TIGIT Antibody Segment by Type
1.2.2 Anti-TIGIT Antibody Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTI-TIGIT ANTIBODY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Anti-TIGIT Antibody Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Anti-TIGIT Antibody Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTI-TIGIT ANTIBODY MARKET COMPETITIVE LANDSCAPE
3.1 Global Anti-TIGIT Antibody Sales by Manufacturers (2019-2024)
3.2 Global Anti-TIGIT Antibody Revenue Market Share by Manufacturers (2019-2024)
3.3 Anti-TIGIT Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti-TIGIT Antibody Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anti-TIGIT Antibody Sales Sites, Area Served, Product Type
3.6 Anti-TIGIT Antibody Market Competitive Situation and Trends
3.6.1 Anti-TIGIT Antibody Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-TIGIT Antibody Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTI-TIGIT ANTIBODY INDUSTRY CHAIN ANALYSIS
4.1 Anti-TIGIT Antibody Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTI-TIGIT ANTIBODY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTI-TIGIT ANTIBODY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-TIGIT Antibody Sales Market Share by Type (2019-2024)
6.3 Global Anti-TIGIT Antibody Market Size Market Share by Type (2019-2024)
6.4 Global Anti-TIGIT Antibody Price by Type (2019-2024)
7 ANTI-TIGIT ANTIBODY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-TIGIT Antibody Market Sales by Application (2019-2024)
7.3 Global Anti-TIGIT Antibody Market Size (M USD) by Application (2019-2024)
7.4 Global Anti-TIGIT Antibody Sales Growth Rate by Application (2019-2024)
8 ANTI-TIGIT ANTIBODY MARKET SEGMENTATION BY REGION
8.1 Global Anti-TIGIT Antibody Sales by Region
8.1.1 Global Anti-TIGIT Antibody Sales by Region
8.1.2 Global Anti-TIGIT Antibody Sales Market Share by Region
8.2 North America
8.2.1 North America Anti-TIGIT Antibody Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-TIGIT Antibody Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-TIGIT Antibody Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-TIGIT Antibody Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-TIGIT Antibody Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Roche
9.1.1 Roche Anti-TIGIT Antibody Basic Information
9.1.2 Roche Anti-TIGIT Antibody Product Overview
9.1.3 Roche Anti-TIGIT Antibody Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Anti-TIGIT Antibody SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Merck
9.2.1 Merck Anti-TIGIT Antibody Basic Information
9.2.2 Merck Anti-TIGIT Antibody Product Overview
9.2.3 Merck Anti-TIGIT Antibody Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Anti-TIGIT Antibody SWOT Analysis
9.2.6 Merck Recent Developments
9.3 AstraZeneca
9.3.1 AstraZeneca Anti-TIGIT Antibody Basic Information
9.3.2 AstraZeneca Anti-TIGIT Antibody Product Overview
9.3.3 AstraZeneca Anti-TIGIT Antibody Product Market Performance
9.3.4 AstraZeneca Anti-TIGIT Antibody SWOT Analysis
9.3.5 AstraZeneca Business Overview
9.3.6 AstraZeneca Recent Developments
9.4 Arcus
9.4.1 Arcus Anti-TIGIT Antibody Basic Information
9.4.2 Arcus Anti-TIGIT Antibody Product Overview
9.4.3 Arcus Anti-TIGIT Antibody Product Market Performance
9.4.4 Arcus Business Overview
9.4.5 Arcus Recent Developments
9.5 Astellas
9.5.1 Astellas Anti-TIGIT Antibody Basic Information
9.5.2 Astellas Anti-TIGIT Antibody Product Overview
9.5.3 Astellas Anti-TIGIT Antibody Product Market Performance
9.5.4 Astellas Business Overview
9.5.5 Astellas Recent Developments
9.6 BeiGene
9.6.1 BeiGene Anti-TIGIT Antibody Basic Information
9.6.2 BeiGene Anti-TIGIT Antibody Product Overview
9.6.3 BeiGene Anti-TIGIT Antibody Product Market Performance
9.6.4 BeiGene Business Overview
9.6.5 BeiGene Recent Developments
9.7 BMS
9.7.1 BMS Anti-TIGIT Antibody Basic Information
9.7.2 BMS Anti-TIGIT Antibody Product Overview
9.7.3 BMS Anti-TIGIT Antibody Product Market Performance
9.7.4 BMS Business Overview
9.7.5 BMS Recent Developments
9.8 Junshi Biosciences
9.8.1 Junshi Biosciences Anti-TIGIT Antibody Basic Information
9.8.2 Junshi Biosciences Anti-TIGIT Antibody Product Overview
9.8.3 Junshi Biosciences Anti-TIGIT Antibody Product Market Performance
9.8.4 Junshi Biosciences Business Overview
9.8.5 Junshi Biosciences Recent Developments
9.9 Innovent Biologics
9.9.1 Innovent Biologics Anti-TIGIT Antibody Basic Information
9.9.2 Innovent Biologics Anti-TIGIT Antibody Product Overview
9.9.3 Innovent Biologics Anti-TIGIT Antibody Product Market Performance
9.9.4 Innovent Biologics Business Overview
9.9.5 Innovent Biologics Recent Developments
9.10 Mereo BioPharma
9.10.1 Mereo BioPharma Anti-TIGIT Antibody Basic Information
9.10.2 Mereo BioPharma Anti-TIGIT Antibody Product Overview
9.10.3 Mereo BioPharma Anti-TIGIT Antibody Product Market Performance
9.10.4 Mereo BioPharma Business Overview
9.10.5 Mereo BioPharma Recent Developments
9.11 Seattle Genetics
9.11.1 Seattle Genetics Anti-TIGIT Antibody Basic Information
9.11.2 Seattle Genetics Anti-TIGIT Antibody Product Overview
9.11.3 Seattle Genetics Anti-TIGIT Antibody Product Market Performance
9.11.4 Seattle Genetics Business Overview
9.11.5 Seattle Genetics Recent Developments
9.12 Hengrui Medicine
9.12.1 Hengrui Medicine Anti-TIGIT Antibody Basic Information
9.12.2 Hengrui Medicine Anti-TIGIT Antibody Product Overview
9.12.3 Hengrui Medicine Anti-TIGIT Antibody Product Market Performance
9.12.4 Hengrui Medicine Business Overview
9.12.5 Hengrui Medicine Recent Developments
9.13 Compugen
9.13.1 Compugen Anti-TIGIT Antibody Basic Information
9.13.2 Compugen Anti-TIGIT Antibody Product Overview
9.13.3 Compugen Anti-TIGIT Antibody Product Market Performance
9.13.4 Compugen Business Overview
9.13.5 Compugen Recent Developments
9.14 Gilead Sciences
9.14.1 Gilead Sciences Anti-TIGIT Antibody Basic Information
9.14.2 Gilead Sciences Anti-TIGIT Antibody Product Overview
9.14.3 Gilead Sciences Anti-TIGIT Antibody Product Market Performance
9.14.4 Gilead Sciences Business Overview
9.14.5 Gilead Sciences Recent Developments
10 ANTI-TIGIT ANTIBODY MARKET FORECAST BY REGION
10.1 Global Anti-TIGIT Antibody Market Size Forecast
10.2 Global Anti-TIGIT Antibody Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anti-TIGIT Antibody Market Size Forecast by Country
10.2.3 Asia Pacific Anti-TIGIT Antibody Market Size Forecast by Region
10.2.4 South America Anti-TIGIT Antibody Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Anti-TIGIT Antibody by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Anti-TIGIT Antibody Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Anti-TIGIT Antibody by Type (2025-2030)
11.1.2 Global Anti-TIGIT Antibody Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Anti-TIGIT Antibody by Type (2025-2030)
11.2 Global Anti-TIGIT Antibody Market Forecast by Application (2025-2030)
11.2.1 Global Anti-TIGIT Antibody Sales (Kilotons) Forecast by Application
11.2.2 Global Anti-TIGIT Antibody Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-TIGIT Antibody Market Size Comparison by Region (M USD)
Table 5. Global Anti-TIGIT Antibody Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Anti-TIGIT Antibody Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anti-TIGIT Antibody Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anti-TIGIT Antibody Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-TIGIT Antibody as of 2022)
Table 10. Global Market Anti-TIGIT Antibody Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anti-TIGIT Antibody Sales Sites and Area Served
Table 12. Manufacturers Anti-TIGIT Antibody Product Type
Table 13. Global Anti-TIGIT Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti-TIGIT Antibody
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-TIGIT Antibody Market Challenges
Table 22. Global Anti-TIGIT Antibody Sales by Type (Kilotons)
Table 23. Global Anti-TIGIT Antibody Market Size by Type (M USD)
Table 24. Global Anti-TIGIT Antibody Sales (Kilotons) by Type (2019-2024)
Table 25. Global Anti-TIGIT Antibody Sales Market Share by Type (2019-2024)
Table 26. Global Anti-TIGIT Antibody Market Size (M USD) by Type (2019-2024)
Table 27. Global Anti-TIGIT Antibody Market Size Share by Type (2019-2024)
Table 28. Global Anti-TIGIT Antibody Price (USD/Ton) by Type (2019-2024)
Table 29. Global Anti-TIGIT Antibody Sales (Kilotons) by Application
Table 30. Global Anti-TIGIT Antibody Market Size by Application
Table 31. Global Anti-TIGIT Antibody Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Anti-TIGIT Antibody Sales Market Share by Application (2019-2024)
Table 33. Global Anti-TIGIT Antibody Sales by Application (2019-2024) & (M USD)
Table 34. Global Anti-TIGIT Antibody Market Share by Application (2019-2024)
Table 35. Global Anti-TIGIT Antibody Sales Growth Rate by Application (2019-2024)
Table 36. Global Anti-TIGIT Antibody Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Anti-TIGIT Antibody Sales Market Share by Region (2019-2024)
Table 38. North America Anti-TIGIT Antibody Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Anti-TIGIT Antibody Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Anti-TIGIT Antibody Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Anti-TIGIT Antibody Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Anti-TIGIT Antibody Sales by Region (2019-2024) & (Kilotons)
Table 43. Roche Anti-TIGIT Antibody Basic Information
Table 44. Roche Anti-TIGIT Antibody Product Overview
Table 45. Roche Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Roche Business Overview
Table 47. Roche Anti-TIGIT Antibody SWOT Analysis
Table 48. Roche Recent Developments
Table 49. Merck Anti-TIGIT Antibody Basic Information
Table 50. Merck Anti-TIGIT Antibody Product Overview
Table 51. Merck Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Merck Business Overview
Table 53. Merck Anti-TIGIT Antibody SWOT Analysis
Table 54. Merck Recent Developments
Table 55. AstraZeneca Anti-TIGIT Antibody Basic Information
Table 56. AstraZeneca Anti-TIGIT Antibody Product Overview
Table 57. AstraZeneca Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. AstraZeneca Anti-TIGIT Antibody SWOT Analysis
Table 59. AstraZeneca Business Overview
Table 60. AstraZeneca Recent Developments
Table 61. Arcus Anti-TIGIT Antibody Basic Information
Table 62. Arcus Anti-TIGIT Antibody Product Overview
Table 63. Arcus Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Arcus Business Overview
Table 65. Arcus Recent Developments
Table 66. Astellas Anti-TIGIT Antibody Basic Information
Table 67. Astellas Anti-TIGIT Antibody Product Overview
Table 68. Astellas Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Astellas Business Overview
Table 70. Astellas Recent Developments
Table 71. BeiGene Anti-TIGIT Antibody Basic Information
Table 72. BeiGene Anti-TIGIT Antibody Product Overview
Table 73. BeiGene Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. BeiGene Business Overview
Table 75. BeiGene Recent Developments
Table 76. BMS Anti-TIGIT Antibody Basic Information
Table 77. BMS Anti-TIGIT Antibody Product Overview
Table 78. BMS Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. BMS Business Overview
Table 80. BMS Recent Developments
Table 81. Junshi Biosciences Anti-TIGIT Antibody Basic Information
Table 82. Junshi Biosciences Anti-TIGIT Antibody Product Overview
Table 83. Junshi Biosciences Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Junshi Biosciences Business Overview
Table 85. Junshi Biosciences Recent Developments
Table 86. Innovent Biologics Anti-TIGIT Antibody Basic Information
Table 87. Innovent Biologics Anti-TIGIT Antibody Product Overview
Table 88. Innovent Biologics Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Innovent Biologics Business Overview
Table 90. Innovent Biologics Recent Developments
Table 91. Mereo BioPharma Anti-TIGIT Antibody Basic Information
Table 92. Mereo BioPharma Anti-TIGIT Antibody Product Overview
Table 93. Mereo BioPharma Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Mereo BioPharma Business Overview
Table 95. Mereo BioPharma Recent Developments
Table 96. Seattle Genetics Anti-TIGIT Antibody Basic Information
Table 97. Seattle Genetics Anti-TIGIT Antibody Product Overview
Table 98. Seattle Genetics Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Seattle Genetics Business Overview
Table 100. Seattle Genetics Recent Developments
Table 101. Hengrui Medicine Anti-TIGIT Antibody Basic Information
Table 102. Hengrui Medicine Anti-TIGIT Antibody Product Overview
Table 103. Hengrui Medicine Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Hengrui Medicine Business Overview
Table 105. Hengrui Medicine Recent Developments
Table 106. Compugen Anti-TIGIT Antibody Basic Information
Table 107. Compugen Anti-TIGIT Antibody Product Overview
Table 108. Compugen Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Compugen Business Overview
Table 110. Compugen Recent Developments
Table 111. Gilead Sciences Anti-TIGIT Antibody Basic Information
Table 112. Gilead Sciences Anti-TIGIT Antibody Product Overview
Table 113. Gilead Sciences Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Gilead Sciences Business Overview
Table 115. Gilead Sciences Recent Developments
Table 116. Global Anti-TIGIT Antibody Sales Forecast by Region (2025-2030) & (Kilotons)
Table 117. Global Anti-TIGIT Antibody Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Anti-TIGIT Antibody Sales Forecast by Country (2025-2030) & (Kilotons)
Table 119. North America Anti-TIGIT Antibody Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Anti-TIGIT Antibody Sales Forecast by Country (2025-2030) & (Kilotons)
Table 121. Europe Anti-TIGIT Antibody Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Anti-TIGIT Antibody Sales Forecast by Region (2025-2030) & (Kilotons)
Table 123. Asia Pacific Anti-TIGIT Antibody Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Anti-TIGIT Antibody Sales Forecast by Country (2025-2030) & (Kilotons)
Table 125. South America Anti-TIGIT Antibody Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Anti-TIGIT Antibody Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Anti-TIGIT Antibody Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Anti-TIGIT Antibody Sales Forecast by Type (2025-2030) & (Kilotons)
Table 129. Global Anti-TIGIT Antibody Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Anti-TIGIT Antibody Price Forecast by Type (2025-2030) & (USD/Ton)
Table 131. Global Anti-TIGIT Antibody Sales (Kilotons) Forecast by Application (2025-2030)
Table 132. Global Anti-TIGIT Antibody Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-TIGIT Antibody Market Size Comparison by Region (M USD)
Table 5. Global Anti-TIGIT Antibody Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Anti-TIGIT Antibody Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anti-TIGIT Antibody Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anti-TIGIT Antibody Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-TIGIT Antibody as of 2022)
Table 10. Global Market Anti-TIGIT Antibody Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anti-TIGIT Antibody Sales Sites and Area Served
Table 12. Manufacturers Anti-TIGIT Antibody Product Type
Table 13. Global Anti-TIGIT Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti-TIGIT Antibody
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-TIGIT Antibody Market Challenges
Table 22. Global Anti-TIGIT Antibody Sales by Type (Kilotons)
Table 23. Global Anti-TIGIT Antibody Market Size by Type (M USD)
Table 24. Global Anti-TIGIT Antibody Sales (Kilotons) by Type (2019-2024)
Table 25. Global Anti-TIGIT Antibody Sales Market Share by Type (2019-2024)
Table 26. Global Anti-TIGIT Antibody Market Size (M USD) by Type (2019-2024)
Table 27. Global Anti-TIGIT Antibody Market Size Share by Type (2019-2024)
Table 28. Global Anti-TIGIT Antibody Price (USD/Ton) by Type (2019-2024)
Table 29. Global Anti-TIGIT Antibody Sales (Kilotons) by Application
Table 30. Global Anti-TIGIT Antibody Market Size by Application
Table 31. Global Anti-TIGIT Antibody Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Anti-TIGIT Antibody Sales Market Share by Application (2019-2024)
Table 33. Global Anti-TIGIT Antibody Sales by Application (2019-2024) & (M USD)
Table 34. Global Anti-TIGIT Antibody Market Share by Application (2019-2024)
Table 35. Global Anti-TIGIT Antibody Sales Growth Rate by Application (2019-2024)
Table 36. Global Anti-TIGIT Antibody Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Anti-TIGIT Antibody Sales Market Share by Region (2019-2024)
Table 38. North America Anti-TIGIT Antibody Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Anti-TIGIT Antibody Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Anti-TIGIT Antibody Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Anti-TIGIT Antibody Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Anti-TIGIT Antibody Sales by Region (2019-2024) & (Kilotons)
Table 43. Roche Anti-TIGIT Antibody Basic Information
Table 44. Roche Anti-TIGIT Antibody Product Overview
Table 45. Roche Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Roche Business Overview
Table 47. Roche Anti-TIGIT Antibody SWOT Analysis
Table 48. Roche Recent Developments
Table 49. Merck Anti-TIGIT Antibody Basic Information
Table 50. Merck Anti-TIGIT Antibody Product Overview
Table 51. Merck Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Merck Business Overview
Table 53. Merck Anti-TIGIT Antibody SWOT Analysis
Table 54. Merck Recent Developments
Table 55. AstraZeneca Anti-TIGIT Antibody Basic Information
Table 56. AstraZeneca Anti-TIGIT Antibody Product Overview
Table 57. AstraZeneca Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. AstraZeneca Anti-TIGIT Antibody SWOT Analysis
Table 59. AstraZeneca Business Overview
Table 60. AstraZeneca Recent Developments
Table 61. Arcus Anti-TIGIT Antibody Basic Information
Table 62. Arcus Anti-TIGIT Antibody Product Overview
Table 63. Arcus Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Arcus Business Overview
Table 65. Arcus Recent Developments
Table 66. Astellas Anti-TIGIT Antibody Basic Information
Table 67. Astellas Anti-TIGIT Antibody Product Overview
Table 68. Astellas Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Astellas Business Overview
Table 70. Astellas Recent Developments
Table 71. BeiGene Anti-TIGIT Antibody Basic Information
Table 72. BeiGene Anti-TIGIT Antibody Product Overview
Table 73. BeiGene Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. BeiGene Business Overview
Table 75. BeiGene Recent Developments
Table 76. BMS Anti-TIGIT Antibody Basic Information
Table 77. BMS Anti-TIGIT Antibody Product Overview
Table 78. BMS Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. BMS Business Overview
Table 80. BMS Recent Developments
Table 81. Junshi Biosciences Anti-TIGIT Antibody Basic Information
Table 82. Junshi Biosciences Anti-TIGIT Antibody Product Overview
Table 83. Junshi Biosciences Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Junshi Biosciences Business Overview
Table 85. Junshi Biosciences Recent Developments
Table 86. Innovent Biologics Anti-TIGIT Antibody Basic Information
Table 87. Innovent Biologics Anti-TIGIT Antibody Product Overview
Table 88. Innovent Biologics Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Innovent Biologics Business Overview
Table 90. Innovent Biologics Recent Developments
Table 91. Mereo BioPharma Anti-TIGIT Antibody Basic Information
Table 92. Mereo BioPharma Anti-TIGIT Antibody Product Overview
Table 93. Mereo BioPharma Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Mereo BioPharma Business Overview
Table 95. Mereo BioPharma Recent Developments
Table 96. Seattle Genetics Anti-TIGIT Antibody Basic Information
Table 97. Seattle Genetics Anti-TIGIT Antibody Product Overview
Table 98. Seattle Genetics Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Seattle Genetics Business Overview
Table 100. Seattle Genetics Recent Developments
Table 101. Hengrui Medicine Anti-TIGIT Antibody Basic Information
Table 102. Hengrui Medicine Anti-TIGIT Antibody Product Overview
Table 103. Hengrui Medicine Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Hengrui Medicine Business Overview
Table 105. Hengrui Medicine Recent Developments
Table 106. Compugen Anti-TIGIT Antibody Basic Information
Table 107. Compugen Anti-TIGIT Antibody Product Overview
Table 108. Compugen Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Compugen Business Overview
Table 110. Compugen Recent Developments
Table 111. Gilead Sciences Anti-TIGIT Antibody Basic Information
Table 112. Gilead Sciences Anti-TIGIT Antibody Product Overview
Table 113. Gilead Sciences Anti-TIGIT Antibody Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Gilead Sciences Business Overview
Table 115. Gilead Sciences Recent Developments
Table 116. Global Anti-TIGIT Antibody Sales Forecast by Region (2025-2030) & (Kilotons)
Table 117. Global Anti-TIGIT Antibody Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Anti-TIGIT Antibody Sales Forecast by Country (2025-2030) & (Kilotons)
Table 119. North America Anti-TIGIT Antibody Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Anti-TIGIT Antibody Sales Forecast by Country (2025-2030) & (Kilotons)
Table 121. Europe Anti-TIGIT Antibody Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Anti-TIGIT Antibody Sales Forecast by Region (2025-2030) & (Kilotons)
Table 123. Asia Pacific Anti-TIGIT Antibody Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Anti-TIGIT Antibody Sales Forecast by Country (2025-2030) & (Kilotons)
Table 125. South America Anti-TIGIT Antibody Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Anti-TIGIT Antibody Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Anti-TIGIT Antibody Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Anti-TIGIT Antibody Sales Forecast by Type (2025-2030) & (Kilotons)
Table 129. Global Anti-TIGIT Antibody Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Anti-TIGIT Antibody Price Forecast by Type (2025-2030) & (USD/Ton)
Table 131. Global Anti-TIGIT Antibody Sales (Kilotons) Forecast by Application (2025-2030)
Table 132. Global Anti-TIGIT Antibody Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Anti-TIGIT Antibody
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-TIGIT Antibody Market Size (M USD), 2019-2030
Figure 5. Global Anti-TIGIT Antibody Market Size (M USD) (2019-2030)
Figure 6. Global Anti-TIGIT Antibody Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-TIGIT Antibody Market Size by Country (M USD)
Figure 11. Anti-TIGIT Antibody Sales Share by Manufacturers in 2023
Figure 12. Global Anti-TIGIT Antibody Revenue Share by Manufacturers in 2023
Figure 13. Anti-TIGIT Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anti-TIGIT Antibody Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-TIGIT Antibody Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anti-TIGIT Antibody Market Share by Type
Figure 18. Sales Market Share of Anti-TIGIT Antibody by Type (2019-2024)
Figure 19. Sales Market Share of Anti-TIGIT Antibody by Type in 2023
Figure 20. Market Size Share of Anti-TIGIT Antibody by Type (2019-2024)
Figure 21. Market Size Market Share of Anti-TIGIT Antibody by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anti-TIGIT Antibody Market Share by Application
Figure 24. Global Anti-TIGIT Antibody Sales Market Share by Application (2019-2024)
Figure 25. Global Anti-TIGIT Antibody Sales Market Share by Application in 2023
Figure 26. Global Anti-TIGIT Antibody Market Share by Application (2019-2024)
Figure 27. Global Anti-TIGIT Antibody Market Share by Application in 2023
Figure 28. Global Anti-TIGIT Antibody Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anti-TIGIT Antibody Sales Market Share by Region (2019-2024)
Figure 30. North America Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Anti-TIGIT Antibody Sales Market Share by Country in 2023
Figure 32. U.S. Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Anti-TIGIT Antibody Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Anti-TIGIT Antibody Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Anti-TIGIT Antibody Sales Market Share by Country in 2023
Figure 37. Germany Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Anti-TIGIT Antibody Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Anti-TIGIT Antibody Sales Market Share by Region in 2023
Figure 44. China Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Anti-TIGIT Antibody Sales and Growth Rate (Kilotons)
Figure 50. South America Anti-TIGIT Antibody Sales Market Share by Country in 2023
Figure 51. Brazil Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Anti-TIGIT Antibody Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Anti-TIGIT Antibody Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Anti-TIGIT Antibody Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Anti-TIGIT Antibody Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Anti-TIGIT Antibody Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Anti-TIGIT Antibody Market Share Forecast by Type (2025-2030)
Figure 65. Global Anti-TIGIT Antibody Sales Forecast by Application (2025-2030)
Figure 66. Global Anti-TIGIT Antibody Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Anti-TIGIT Antibody
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-TIGIT Antibody Market Size (M USD), 2019-2030
Figure 5. Global Anti-TIGIT Antibody Market Size (M USD) (2019-2030)
Figure 6. Global Anti-TIGIT Antibody Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-TIGIT Antibody Market Size by Country (M USD)
Figure 11. Anti-TIGIT Antibody Sales Share by Manufacturers in 2023
Figure 12. Global Anti-TIGIT Antibody Revenue Share by Manufacturers in 2023
Figure 13. Anti-TIGIT Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anti-TIGIT Antibody Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-TIGIT Antibody Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anti-TIGIT Antibody Market Share by Type
Figure 18. Sales Market Share of Anti-TIGIT Antibody by Type (2019-2024)
Figure 19. Sales Market Share of Anti-TIGIT Antibody by Type in 2023
Figure 20. Market Size Share of Anti-TIGIT Antibody by Type (2019-2024)
Figure 21. Market Size Market Share of Anti-TIGIT Antibody by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anti-TIGIT Antibody Market Share by Application
Figure 24. Global Anti-TIGIT Antibody Sales Market Share by Application (2019-2024)
Figure 25. Global Anti-TIGIT Antibody Sales Market Share by Application in 2023
Figure 26. Global Anti-TIGIT Antibody Market Share by Application (2019-2024)
Figure 27. Global Anti-TIGIT Antibody Market Share by Application in 2023
Figure 28. Global Anti-TIGIT Antibody Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anti-TIGIT Antibody Sales Market Share by Region (2019-2024)
Figure 30. North America Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Anti-TIGIT Antibody Sales Market Share by Country in 2023
Figure 32. U.S. Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Anti-TIGIT Antibody Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Anti-TIGIT Antibody Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Anti-TIGIT Antibody Sales Market Share by Country in 2023
Figure 37. Germany Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Anti-TIGIT Antibody Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Anti-TIGIT Antibody Sales Market Share by Region in 2023
Figure 44. China Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Anti-TIGIT Antibody Sales and Growth Rate (Kilotons)
Figure 50. South America Anti-TIGIT Antibody Sales Market Share by Country in 2023
Figure 51. Brazil Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Anti-TIGIT Antibody Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Anti-TIGIT Antibody Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Anti-TIGIT Antibody Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Anti-TIGIT Antibody Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Anti-TIGIT Antibody Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Anti-TIGIT Antibody Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Anti-TIGIT Antibody Market Share Forecast by Type (2025-2030)
Figure 65. Global Anti-TIGIT Antibody Sales Forecast by Application (2025-2030)
Figure 66. Global Anti-TIGIT Antibody Market Share Forecast by Application (2025-2030)